{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T20:57:50Z","timestamp":1792616270685,"version":"4.5.0"},"reference-count":77,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T00:00:00Z","timestamp":1548201600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.jaad.2019.01.004","type":"journal-article","created":{"date-parts":[[2019,1,14]],"date-time":"2019-01-14T19:11:37Z","timestamp":1547493097000},"page":"1435-1444","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":72,"title":["Efficacy and safety of antiscabietic agents: A systematic review and network meta-analysis of randomized controlled trials"],"prefix":"10.1016","volume":"80","author":[{"given":"Kunlawat","family":"Thadanipon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thunyarat","family":"Anothaisintawee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sasivimol","family":"Rattanasiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ammarin","family":"Thakkinstian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Attia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2019.01.004_bib1","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/S1473-3099(15)00132-2","article-title":"Prevalence of scabies and impetigo worldwide: a systematic review","volume":"15","author":"Romani","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jaad.2019.01.004_bib2","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1001\/jamadermatol.2014.709","article-title":"Global burden of skin disease as reflected in Cochrane Database of Systematic Reviews","volume":"150","author":"Karimkhani","year":"2014","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaad.2019.01.004_bib3","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1016\/S0140-6736(06)68772-2","article-title":"Scabies","volume":"367","author":"Heukelbach","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2019.01.004_bib4","first-page":"CD000320","article-title":"Interventions for treating scabies","author":"Strong","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jaad.2019.01.004_bib5","first-page":"757","article-title":"Originalarbeit: therapie der skabies: systematische literatur\u00fcbersicht von randomisierten kontrollierten Studien","volume":"113","author":"Dressler","year":"2016","journal-title":"Dtsch Arztebl Int"},{"key":"10.1016\/j.jaad.2019.01.004_bib6","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.jaad.2017.09.006","article-title":"Ivermectin versus permethrin in the treatment of scabies: a systematic review and meta-analysis of randomized controlled trials","volume":"78","author":"Dhana","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2019.01.004_bib7","first-page":"Cd012994","article-title":"Ivermectin and permethrin for treating scabies","volume":"4","author":"Rosumeck","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jaad.2019.01.004_bib8","series-title":"Use of Mixed Treatment Comparisons in Systematic Reviews. Methods Research Reports","author":"Coleman","year":"2012"},{"key":"10.1016\/j.jaad.2019.01.004_bib9","doi-asserted-by":"crossref","first-page":"777","DOI":"10.7326\/M14-2385","article-title":"The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations","volume":"162","author":"Hutton","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaad.2019.01.004_bib10","series-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 510 (updated March 2011)","article-title":"Assessing risk of bias in included studies","author":"Higgins","year":"2011"},{"key":"10.1016\/j.jaad.2019.01.004_bib11","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1185\/03007990802215315","article-title":"Analytical approaches to reporting long-term clinical trial data","volume":"24","author":"Papp","year":"2008","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.jaad.2019.01.004_bib12","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1177\/1536867X0900900103","article-title":"Multivariate random-effects meta-analysis","volume":"9","author":"White","year":"2009","journal-title":"Stata J"},{"key":"10.1016\/j.jaad.2019.01.004_bib13","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1177\/1536867X1501500403","article-title":"Network meta-analysis","volume":"15","author":"White","year":"2015","journal-title":"Stata J"},{"key":"10.1016\/j.jaad.2019.01.004_bib14","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/jrsm.1044","article-title":"Consistency and inconsistency in network meta-analysis: concepts and models for multi-arm studies","volume":"3","author":"Higgins","year":"2012","journal-title":"Res Synth Methods"},{"key":"10.1016\/j.jaad.2019.01.004_bib15","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/jrsm.1188","article-title":"The design-by-treatment interaction model: a unifying framework for modelling loop inconsistency in network meta-analysis","volume":"7","author":"Jackson","year":"2016","journal-title":"Res Synth Methods"},{"key":"10.1016\/j.jaad.2019.01.004_bib16","doi-asserted-by":"crossref","first-page":"e76654","DOI":"10.1371\/journal.pone.0076654","article-title":"Graphical tools for network meta-analysis in STATA","volume":"8","author":"Chaimani","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jaad.2019.01.004_bib17","series-title":"Stata Statistical Software: Release 15","year":"2017"},{"key":"10.1016\/j.jaad.2019.01.004_bib18","series-title":"NCT02094716. A dose ranging vehicle controlled study to determine the safety and efficacy of permethrin foam, 5% and permethrin foam, 4% for the treatment of scabies","year":"2014"},{"key":"10.1016\/j.jaad.2019.01.004_bib19","doi-asserted-by":"crossref","first-page":"473","DOI":"10.3109\/09546634.2016.1151855","article-title":"Efficacy, acceptability and cost effectiveness of four therapeutic agents for treatment of scabies","volume":"27","author":"Abdel-Raheem","year":"2016","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.jaad.2019.01.004_bib20","first-page":"283","article-title":"Treatment of scabies: comparison of lindane 1% vs permethrin 5","volume":"13","author":"Rezaee","year":"2015","journal-title":"Skinmed"},{"key":"10.1016\/j.jaad.2019.01.004_bib21","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/dth.12310","article-title":"Clinical efficacy and safety of topical versus oral ivermectin in treatment of uncomplicated scabies","volume":"29","author":"Ahmad","year":"2016","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.jaad.2019.01.004_bib22","first-page":"79","article-title":"The efficacy of oral ivermectin vs. sulfur 10% ointment for the treatment of scabies","volume":"61","author":"Alipour","year":"2015","journal-title":"Ann Parasitol"},{"key":"10.1016\/j.jaad.2019.01.004_bib23","first-page":"284","article-title":"Comparing the efficacy of oral ivermectin vs malathion 0.5% lotion for the treatment of scabies","volume":"12","author":"Goldust","year":"2014","journal-title":"Skinmed"},{"key":"10.1016\/j.jaad.2019.01.004_bib24","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1111\/ijd.12447","article-title":"Topical ivermectin versus crotamiton cream 10% for the treatment of scabies","volume":"53","author":"Goldust","year":"2014","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2019.01.004_bib25","first-page":"79","article-title":"Treatment of scabies: the topical ivermectin vs. permethrin 2.5% cream","volume":"59","author":"Goldust","year":"2013","journal-title":"Ann Parasitol"},{"key":"10.1016\/j.jaad.2019.01.004_bib26","first-page":"37","article-title":"Ivermectin vs. lindane in the treatment of scabies","volume":"59","author":"Goldust","year":"2013","journal-title":"Ann Parasitol"},{"key":"10.1016\/j.jaad.2019.01.004_bib27","first-page":"31","article-title":"Comparison of permethrin 2.5 % cream vs. Tenutex emulsion for the treatment of scabies","volume":"59","author":"Goldust","year":"2013","journal-title":"Ann Parasitol"},{"key":"10.1016\/j.jaad.2019.01.004_bib28","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3109\/15569527.2013.768258","article-title":"Comparison of oral ivermectin versus crotamiton 10% cream in the treatment of scabies","volume":"33","author":"Goldust","year":"2014","journal-title":"Cutan Ocul Toxicol"},{"key":"10.1016\/j.jaad.2019.01.004_bib29","first-page":"251","article-title":"Treatment of scabies: comparison of ivermectin vs. lindane lotion 1%","volume":"20","author":"Mohebbipour","year":"2012","journal-title":"Acta Dermatovenerol Croat"},{"key":"10.1016\/j.jaad.2019.01.004_bib30","first-page":"143","article-title":"Treatment of scabies, permethrin 5% cream vs. crotamiton 10% cream","volume":"59","author":"Pourhasan","year":"2013","journal-title":"Ann Parasitol"},{"key":"10.1016\/j.jaad.2019.01.004_bib31","first-page":"189","article-title":"The efficacy of permethrin 5% vs. oral ivermectin for the treatment of scabies","volume":"59","author":"Ranjkesh","year":"2013","journal-title":"Ann Parasitol"},{"key":"10.1016\/j.jaad.2019.01.004_bib32","doi-asserted-by":"crossref","first-page":"605","DOI":"10.4103\/0378-6323.100571","article-title":"Comparative efficacy and safety of topical permethrin, topical ivermectin, and oral ivermectin in patients of uncomplicated scabies","volume":"78","author":"Chhaiya","year":"2012","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.jaad.2019.01.004_bib33","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/j.1346-8138.2011.01481.x","article-title":"Treatment of scabies: comparison of permethrin 5% versus ivermectin","volume":"39","author":"Goldust","year":"2012","journal-title":"J Dermatol"},{"key":"10.1016\/j.jaad.2019.01.004_bib34","doi-asserted-by":"crossref","first-page":"581","DOI":"10.4103\/0378-6323.84063","article-title":"Topical permethrin and oral ivermectin in the management of scabies: a prospective, randomized, double blind, controlled study","volume":"77","author":"Sharma","year":"2011","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.jaad.2019.01.004_bib35","doi-asserted-by":"crossref","first-page":"424","DOI":"10.2471\/BLT.08.052308","article-title":"Ivermectin versus benzyl benzoate applied once or twice to treat human scabies in Dakar, Senegal: a randomized controlled trial","volume":"87","author":"Ly","year":"2009","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.jaad.2019.01.004_bib36","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1002\/ptr.2614","article-title":"Preliminary study of effectiveness of aloe vera in scabies treatment","volume":"23","author":"Oyelami","year":"2009","journal-title":"Phytother Res"},{"key":"10.1016\/j.jaad.2019.01.004_bib37","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/j.1468-3083.2006.01623.x","article-title":"Efficacy and tolerability of a new synergized pyrethrins thermofobic foam in comparison with benzyl benzoate in the treatment of scabies in convicts: the ISAC study (Studio Della scabbia in ambiente carcerario)","volume":"20","author":"Biele","year":"2006","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2019.01.004_bib38","doi-asserted-by":"crossref","first-page":"33","DOI":"10.4103\/0378-6323.19715","article-title":"Comparison of the efficacy of topical 1% lindane vs 5% permethrin in scabies: a randomized, double-blind study","volume":"72","author":"Zargari","year":"2006","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"Suppl 3","key":"10.1016\/j.jaad.2019.01.004_bib39","first-page":"S531","article-title":"A comparative study between 10 per cent sulfur ointment and 0.3 per cent gamma benzene hexachloride gel in the treatment of scabies in children","volume":"86","author":"Singalavanija","year":"2003","journal-title":"J Med Assoc Thai"},{"key":"10.1016\/j.jaad.2019.01.004_bib40","first-page":"69","article-title":"Efficacy and tolerability of natural synergised pyrethrins in a new thermo labile foam formulation in topical treatment of scabies: a prospective, randomised, investigator-blinded, comparative trial vs. permethrin cream","volume":"13","author":"Amerio","year":"2003","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.jaad.2019.01.004_bib41","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1046\/j.1440-1754.2002.00015.x","article-title":"Ivermectin is better than benzyl benzoate for childhood scabies in developing countries","volume":"38","author":"Brooks","year":"2002","journal-title":"J Paediatr Child Health"},{"key":"10.1016\/j.jaad.2019.01.004_bib42","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1346-8138.2001.tb00015.x","article-title":"Oral ivermectin in scabies patients: a comparison with 1% topical lindane lotion","volume":"28","author":"Madan","year":"2001","journal-title":"J Dermatol"},{"key":"10.1016\/j.jaad.2019.01.004_bib43","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1177\/004947550103100105","article-title":"Successful treatment of scabies with oral ivermectin in Nigeria","volume":"31","author":"Nnoruka","year":"2001","journal-title":"Trop Doct"},{"key":"10.1016\/j.jaad.2019.01.004_bib44","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/S0190-9622(00)90131-2","article-title":"A comparative study of oral ivermectin and topical permethrin cream in the treatment of scabies","volume":"42","author":"Usha","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2019.01.004_bib45","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1001\/archderm.135.6.651","article-title":"Equivalent therapeutic efficacy and safety of ivermectin and lindane in the treatment of human scabies","volume":"135","author":"Chouela","year":"1999","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2019.01.004_bib46","first-page":"331","article-title":"Comparison of ivermectin and benzyl benzoate for treatment of scabies","volume":"44","author":"Glaziou","year":"1993","journal-title":"Trop Med Parasitol"},{"key":"10.1016\/j.jaad.2019.01.004_bib47","first-page":"201","article-title":"The treatment of scabies with oral ivermectin","volume":"129","author":"Macotela-Ruiz","year":"1993","journal-title":"Gac Med Mex"},{"key":"10.1016\/j.jaad.2019.01.004_bib48","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1365-4362.1992.tb03958.x","article-title":"Permethrin versus crotamiton and lindane in the treatment of scabies","volume":"31","author":"Amer","year":"1992","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2019.01.004_bib49","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/j.1525-1470.1990.tb01078.x","article-title":"Comparison of crotamiton 10% cream (Eurax) and permethrin 5% cream (Elimite) for the treatment of scabies in children","volume":"7","author":"Taplin","year":"1990","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.jaad.2019.01.004_bib50","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1001\/archderm.1990.01670260037006","article-title":"Comparative study of 5% permethrin cream and 1% lindane lotion for the treatment of scabies","volume":"126","author":"Schultz","year":"1990","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2019.01.004_bib51","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S0190-9622(86)70263-6","article-title":"Permethrin 5% dermal cream: a new treatment for scabies","volume":"15","author":"Taplin","year":"1986","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2019.01.004_bib52","first-page":"15","article-title":"Comparing the two treatment regimes for scabies, topical permethrin 5% with oral ivermectin","volume":"28","author":"Shaheen","year":"2017","journal-title":"Med Forum Monthly"},{"key":"10.1016\/j.jaad.2019.01.004_bib53","first-page":"1","article-title":"Comparative efficacy of topical pertmehrin, crotamiton and sulfur ointment in treatment of scabies","volume":"11","author":"Mila-Kierzenkowska","year":"2017","journal-title":"J Arthropod Borne Dis"},{"key":"10.1016\/j.jaad.2019.01.004_bib54","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s13596-015-0192-8","article-title":"Clinical efficacy of a herbo-mineral Unani formulation in scabies: an open-label randomized controlled study","volume":"15","author":"Rahman","year":"2015","journal-title":"Orient Pharm Exp Med"},{"key":"10.1016\/j.jaad.2019.01.004_bib55","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1097\/IPC.0000000000000295","article-title":"Comparing the topical ivermectin versus Tenutex emulsion for the treatment of scabies","volume":"23","author":"Rezaee","year":"2015","journal-title":"Infect Dis Clin Pract"},{"key":"10.1016\/j.jaad.2019.01.004_bib56","doi-asserted-by":"crossref","first-page":"39","DOI":"10.4103\/0976-500X.107668","article-title":"Efficacy and safety of Tinospora cordifolia lotion in Sarcoptes scabiei var hominis-infected pediatric patients: a single blind, randomized controlled trial","volume":"4","author":"Castillo","year":"2013","journal-title":"J Pharmacol Pharmather"},{"key":"10.1016\/j.jaad.2019.01.004_bib57","first-page":"45","article-title":"A comparison of efficacy of single topical permethrin and single oral ivermectin in the treatment of scabies","volume":"22","author":"Saqib","year":"2012","journal-title":"J Pak Assoc Dermatol"},{"key":"10.1016\/j.jaad.2019.01.004_bib58","first-page":"5706","article-title":"ScaNeem: herbo-mineral therapy for scabies","volume":"5","author":"Ayaz","year":"2011","journal-title":"J Med Plant Res"},{"key":"10.1016\/j.jaad.2019.01.004_bib59","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4103\/0253-7613.48882","article-title":"Comparison of safety, efficacy, and cost effectiveness of benzyl benzoate, permethrin, and ivermectin in patients of scabies","volume":"41","author":"Bachewar","year":"2009","journal-title":"Indian J Pharmacol"},{"key":"10.1016\/j.jaad.2019.01.004_bib60","first-page":"78","article-title":"Ivermectin in the treatment of scabies","volume":"17","author":"Khan","year":"2007","journal-title":"J Pak Assoc Dermatol"},{"key":"10.1016\/j.jaad.2019.01.004_bib61","first-page":"269","article-title":"A family based study on the treatment of scabies with benzyl benzoate and sulphur ointment","volume":"44","author":"Gulati","year":"1978","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.jaad.2019.01.004_bib62","series-title":"A randomized, controlled trial to compare the efficiency of 1% lindane (scabene) cream and 5% permethrim (lotrix) cream for the treatment of scabies","author":"Bokhari","year":"2000"},{"issue":"2","key":"10.1016\/j.jaad.2019.01.004_bib63","first-page":"3","article-title":"The comparison of oral ivrmectin and topical gamma-benzene hexachloridv 1% in treatment of scabies (Persian)","volume":"3","author":"Daneshpajooh","year":"1999","journal-title":"Iran J Dermatol"},{"key":"10.1016\/j.jaad.2019.01.004_bib64","first-page":"228","article-title":"Comparison of efficacy and safety of oral ivermectin with topical permethrin in treatment of scabies","volume":"20","author":"Mushtaq","year":"2010","journal-title":"J Pak Assoc Dermatol"},{"key":"10.1016\/j.jaad.2019.01.004_bib65","first-page":"Hc01","article-title":"Comparative study of efficacy of oral ivermectin versus some topical antiscabies drugs in the treatment of scabies","volume":"8","author":"Manjhi","year":"2014","journal-title":"J Clin Diagn Res"},{"key":"10.1016\/j.jaad.2019.01.004_bib66","first-page":"57","article-title":"Comparative study to test efficacy of topical permethrin and oral ivermectin in the management of scabies - a prospective randomized, single blinded controlled study","volume":"5","author":"Aggarwal","year":"2014","journal-title":"Natl J Integr Res Med"},{"key":"10.1016\/j.jaad.2019.01.004_bib67","first-page":"15","article-title":"An open label, randomized, comparative study of antiscabietic drugs permethrin, gamma benzene hexachloride and ivermectin in patients of uncomplicated scabies","volume":"3","author":"Meenakshi","year":"2014","journal-title":"Int J Pharmacol Clin Sci"},{"key":"10.1016\/j.jaad.2019.01.004_bib68","first-page":"1234","article-title":"Study of efficacy of oral ivermectin in comparison to commonly used topical antiscabetic drugs gamma benzene hexachloride and permethrin","volume":"5","author":"Kanwar","year":"2017","journal-title":"Int J Basic Clin Pharmacol"},{"key":"10.1016\/j.jaad.2019.01.004_bib69","first-page":"67","article-title":"A comparative study of topical permethrin, oral ivermectin and combination of permethrin with ivermectin in patients of scabies","volume":"15","author":"Wankhade","year":"2016","journal-title":"J Dent Med Sci"},{"key":"10.1016\/j.jaad.2019.01.004_bib70","doi-asserted-by":"crossref","first-page":"186","DOI":"10.4103\/0019-5154.27981","article-title":"Evaluation of the commonest site, demographic profile and most effective therapy in scabies","volume":"51","author":"Das","year":"2006","journal-title":"Indian J Dermatol"},{"key":"10.1016\/j.jaad.2019.01.004_bib71","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/S1470-2045(15)70134-8","article-title":"Carcinogenicity of tetrachlorvinphos, parathion, malathion, diazinon, and glyphosate","volume":"16","author":"Guyton","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jaad.2019.01.004_bib72","unstructured":"FDA Public Health Advisory: Safety of Topical Lindane Products for the Treatment of Scabies and Lice."},{"key":"10.1016\/j.jaad.2019.01.004_bib73","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/S1470-2045(15)00081-9","article-title":"Carcinogenicity of lindane, DDT, and 2,4-dichlorophenoxyacetic acid","volume":"16","author":"Loomis","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jaad.2019.01.004_bib74","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.2174\/138920112800399248","article-title":"Ivermectin in human medicine, an overview of the current status of its clinical applications","volume":"13","author":"Gonzalez","year":"2012","journal-title":"Curr Pharm Biotechnol"},{"key":"10.1016\/j.jaad.2019.01.004_bib75","doi-asserted-by":"crossref","first-page":"546","DOI":"10.4269\/ajtmh.2008.78.546","article-title":"Encephalopathy after ivermectin treatment in a patient infected with Loa loa and Plasmodium spp","volume":"78","author":"Kamgno","year":"2008","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.jaad.2019.01.004_bib76","doi-asserted-by":"crossref","first-page":"28","DOI":"10.4269\/ajtmh.2010.09-0734","article-title":"Analysis of the mdr-1 gene in patients co-infected with Onchocerca volvulus and Loa loa who experienced a post-ivermectin serious adverse event","volume":"83","author":"Bourguinat","year":"2010","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.jaad.2019.01.004_bib77","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1111\/jdv.14351","article-title":"European guideline for the management of scabies","volume":"31","author":"Salavastru","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962219300714?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962219300714?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:51:58Z","timestamp":1759272718000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962219300714"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":77,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S0190962219300714"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2019.01.004","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of antiscabietic agents: A systematic review and network meta-analysis of randomized controlled trials","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2019.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}